Unattached fraction of radon progeny as an experimental tool in the assessment of the risk of nanoparticles

Aerosols Handbook: Measurement, Dosimetry, and Health Effects, Second Edition

Volumn , Issue , 2012, Pages 415-437

  Ruzer, Lev S ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; NANOPARTICLES; RADON;

DECAY PRODUCTS; GLOBAL PROBLEMS; HEALTH EFFECTS; NANOAEROSOL; NANOAEROSOLS; RADON PROGENY; UNATTACHED FRACTION;

RISK ASSESSMENT;

EID: 84922285209     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12668     Document Type: Chapter

References (58)

1. Aitken, RJ, Creely, KS, Tran, CL. Nanoparticles: An occupational hygiene review. Prepared by the Institute of Occupational Medicine for Health and Safety Executive. Edinburgh; Research Report 174; Nanotechnology Now (July 17, 2007) www.nanotech-now.com (2004).
2. Antipin, NI, Kuznetzov, YuV, Ruzer, LS. Instrument for determination of the filtration ability of lungs. At. Energy, 40, 371-372 (1978).
3. ASCC. A review of the potential occupational health & safety implications of nanotechnology. Australian Government; Australian Safety and Compensation Council. http://www.ascc.gov.au/ascc/AboutUs/Publications/ResearchReports/ (2006).
4. Balásházy, I, Hoffman, W. Bronchial airway quantification of local deposition bifurcations. Health Phys., 78(2), 147-158 (2000).
5. Banse, DF, Esfeld, K, Hermann, M, Sierau, B, Wiedensohler, A. Particle counting efficiency of the TSI CPC 3762 for different operating parameters. J. Aerosol Sci., 32(1), 157-161 (2001).
6. Bhabra, G, Sood, A, Fisher, B, Cartwright, L, Saunders, M, Evans, WH, Surprenant, A, et al. Roger Newson & Charles Patrick Case. Nanoparticles can cause DNA damage across a cellular barrier. Nat. Nanotechnol., 4, 876-883 (2009).
7. Brown, DM, Wilson, MR, MacNee, W, Stone, V, Donaldson, K. Side-dependent proinflammatory effect of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol., 175, 191-199 (2001).
8. Butterweck, G, Vezzu, G, Schuler, Ch, Muller, R, Marsh, JW, Thrift, S, Birchall, A. In vivo measurement of unattached radon progeny deposited in the human respiratory tract. Radiat. Prot. Dosimetry, 94(3), 247-250 (2001).
9. Darby, S, Hill, D, Auvinen, A, Barros-Dios, JM, Baysson, H, Bochicchio, F, Deo H, et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. BMJ. DOI:10. 1136/bmj.38308.477650.63 (published December 21, 2004).
10. DEFRA. Characterising the potential risks posed by engineered nanoparticles; A Second UK Government Research Report. Department for Environment, Food and Rural Affairs, London, U.K. http://www.defra.gov.uk/environment/nanotech/research/pdf/nanoparticles-riskreport07.pdf (2007).
11. Dokukina, VL, Ruzer, LS. Proceedings of All-Union Institute of Physico-Technical and Radiotechnical Measurements (VNIIFTRI). Moscow (in Russian) 30(60) (1976).
12. Donaldson, K, Li, XY, MacNee, W. Ultrafine (nanometer) particle mediated lung injury. J. Aerosol Sci., 29(5/6), 553-560 (1998).
13. Duan, N, Ott, WR. Comprehensive definitions of exposure and dose to environment pollution, in Proceedings of the EPA/AWMA Specialty Conference on Total Exposure Assessment Methodology, Las Vegas, NV (November 1989).
14. Duffin, R, Tran, L, Brown, D, Stone, V, Donaldson, K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol., 19, 849-856 (2007).
15. EPA. Review of the National Ambient Air Quality Standards for Particular Matter: Policy Assessment of Scientific and Technical Information, OAQPS Staff Paper, EPA/452/R-96-013, Office of Air Quality Planning and Standards, Research Triangle Park, NC (1996).
16. Friends of the Earth Nanotechnology Project. Workplace exposure to nanomaterials and the question of will nano be the next asbestos. AzoNano.com (2009)
17. Geiser, M, Rothen-Rutishauser, B, Kapp, N, Schürch, S, IOM, Project CB0407. CELL PEN: A study to identify the physico-chemical factors controlling the capacity of nanoparticles to penetrate cells (August 12, 2008).
18. Geraci, C. An Update of NIOSH Nanotechnology Research Program. Berkeley, CA: US School of Public Health. Nanoparticle Safety Symposium (2009).
19. Hankin, M, Tran, CL, Ross, B, Donaldson, K, Stone, V, Chaud, QM, Project CB0407, August 12, 2008, Cell pen: A study to identify the physico-chemical factors controlling the capacity of nanoparticles to penetrtate cells. Nanoparticle Surface Area Monitor, TSI Incorporated. June 2005. http://www.particle.tsi.com
20. Kao, CH, ChangLai, SP, Shen, YY, Lee, JK, Wang, SJ. Technetium-99m tetrofosmin SPECT imaging of lung masses: A negative study. J. Nucl. Med., 38, 1015-1019 (1997).
21. Kelly, RJ. Occupational medicine implications of engineered nanoscale particulate matter. ACS J. Chem. Health Saf. 1-42 (March 2008).
22. Kulinowski, KM. Director, International Council on Nanotechnology Temptation, Temptation: Why easy answers about nanomaterial risk are probably wrong (2009).
23. Martonen, TB, Katz, I, Fults, K, Hickey, AJ. Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns. Pharm. Res., 9(12), 1634-1639 (1992).
24. Maynard, AD. Estimating aerosol surface area from number and mass concentration measurements. Ann. Occup. Hyg., 47(2), 123-144 (2003).
25. Maynard, AD. Nanotechnology: The next big thing, or much ado about nothing? Ann. Occup. Hyg., 51(1), 1-12 (2007).
26. Mills, NL, Amin, N, Robinson, SD, Anand, A, Davies, J, Patel, D, et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Respir. Crit. Care Med., 173(4), 426 (2006).
27. Möller, W, Felten, K, Sommerer, K, Scheuch, G, Meyer, G, Meyer, P, et al. Deposition, retention and translocation of ultra-fine particles from the central airways and lung periphery. Am. J. Respir. Crit. Care Med., 177(4), 426 (2008).
28. Muhlfeld, C, Geiser, M, Kapp, N, Gehr, P, Rorthen-Rutishauser, B. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the “relative deposition index”: Evidence for clearance through microvasculature. Part Fibre Toxicol., 4, 7 (2007).
29. National Academy of Sciences. Human exposure assessment for airborne pollutants. Washington, DC: National Research Council (1991).
30. National Institute for Occupational Safety and Health. Approach to Safe Nanotechnology: An Information Exchange with NIOSH. Atlanta, GA: National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Draft (October 2006a).
31. National Institute for Occupational Safety and Health. Current Ultrafine Particle and Nanotechnology-Related Research. Atlanta, GA: National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (October 27, 2006b). www.cdc.gov/niosh/topics/nanotech/oltrares.html
32. National Research Council, Health Effect of Exposure to Radon, BEIR VI, Washington, DC: National Academy Press (1999).
33. National Science Foundation. NSF Workshop Report on Emerging Issues in Nanoparticle Aerosol Science and Technology (NAST). Los Angeles, CA: University of California (2003).
34. Nemmar, A, Hoet, PHM, Vanquickenborne, B, Dinsdale, D, Thomeer, M, Hoylaerts, MF, Vanbilloen, H, et al. Passage of inhaled particles into the blood circulation in humans. Circulation, 105(4), 411-414 (2002).
35. NIOSH. Strategic Plan for NIOSH Nanotechnology Research-Filling the Knowledge Gaps. Nanotechnology Research Program, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Draft. http://www.cdc.gov/niosh/topics/nanotech/default.html (2005).
36. NIOSH. Approach to Safe Nanotechnology; An Information Exchange with NIOSH; National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Draft (October 2006a).
37. NIOSH. Current Ultrafine Particle and Nanotechnology-Related Research. Atlanta, GA: National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. www.cdc.gov/niosh/topics/nanotech/oltrares.html (October 27, 2006b).
38. Oberdörster, G, Oberdörster, E, Oberdörster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 113, 823-839 (2005).
39. Ott, WR. Concepts of human exposure to air pollution. Environ. Int., 7, 179-196 (1966).
40. PAS BSI 71:2005 Nano particle III-Vs review; 18(5), 5 (June-July 2005) www.bsi-global.com/nano
41. Rejman, J, Oberle, V, Zuhorn, IS, Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J., 377(1), 159-169 (2004).
42. Renn, O, Roco, M. White paper no. 2, nanotechnology risk governance, international risk governance council (IRGC). With annexes, Rocco, M, Litten, E. (eds.). Geneva, Switzerland: IRGC (2006). http://www.irgc.org/Nanotechnology.html
43. Rothen-Rutishauser, BM, Schurch, S, Haenni, B, Kapp, N, Gehr, P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol., 40, 4353-4359 (2006).
44. Ruzer, LS. The method of determining of the absorbed doses in organism upon inhalation of radon. Patent No. 165250. Bull. Invent., 28 (1964a) (in Russian).
45. Ruzer, LS. The method of determining the concentration of the gas. Patent No. 234746. Bull. Invent., 18 (1964b) (in Russian).
46. Ruzer, LS. Radioactive aerosols. Determination of the absorbed dose. Doctoral dissertation, Moscow, USSR (1970) (in Russian).
47. Ruzer, LS. Assessment of nanoparticles surface area by measuring of unattached fraction of radon progeny. J. Nanopart. Res., 10, 761-766 (2008).
48. Ruzer, LS, Apte, MG. Radon progeny as a potential experimental tool in aerosol dosimetry, Frontiers in Aerosol Research, Irvine, CA (October 24-25, 2005).
49. Ruzer, LS, Apte, MG. Unattached radon progeny as an experimental tool for dosimetry of nanoaerosols primarily less than 100 nm in size: Proposed method and research strategy. Inhal. Toxicol., 1-7, (2010).
50. Ruzer, LS, Apte, MG. Environmental Energy Technologies Division, Indoor Environment Department Lawrence Berkeley National Laboratory, Berkeley, CA 94720, US. J. Int. Res. Publ.: Ecol. Saf., 5 (2010), ISSN 1313-7999.
51. Ruzer, LS, Harley, NH, eds. Aerosol Handbook: Measurement, Dosimetry, and Health Effects. New York: CRC Press (2004).
52. Ruzer, LS, Nero, AV, Harley, NH. Assessment of lung deposition and breathing rate of underground miners in Tadjikistan. Radiat. Prot. Dosimetry, 58(4), 261-268 (1995).
53. Ruzer, LS, Sextro, RG. Assessment of very low aerosol concentrations by measuring the unattached fraction of 218Po. Radiat. Prot. Dosimetry, 71, 135-140 (1997).
54. SCENIHR. The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies, Health and Consumer Protection Directorate-General, Scientific Committee on Emerging and Newly Identified Health Risks, European Commission, Brussels: European Commission (2006).
55. Shaffer, RE. Respirator Fit: Past, Present, and Future National Institute for Occupational Safety and Health (NIOSH) National Personal Protective Technology Laboratory (NPPTL) No Fit Test Respirator Research Workshop (November 6, 2008).
56. Wiebert, P, Sanchez-Crespo, A, Seitz, J, Falk, R, Philipson, K, Kreyling, WG, Möller, W, et al. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur. Respir. J., 28(2), 286-229 (2006).
57. Wilson, WE, Stanek, J, Pui, DYH, Han, HS. Use of the electrical aerosol detector as an indicator for the total particle surface area deposited in the lung, in Proceedings of Symposium on Air Quality Measurement Methods and Technology, Research Triangle, Park, NC (2004).
58. Zartarian, V, Bahadori, T, Mckone, T. Adoption of an official ISEA glossary. J. Exposure Anal. Environ. Epidemiol., 15, 1-5 (2005).